The Translational Initiative to Map Epigenetics in Aging (TIME-A)

Elysium Health

Status: Not yet enrolling

Conditions: Biological Aging

Study type: Observational

Funder types: Industry

Identifiers

NCT05760547

TIME-A

Details and patient eligibility

About

The Translational Initiative to Map Epigenetics in Aging (TIME-A) study aims to advance our understanding of the connections between epigenetics, lifestyle, demographics, and health and aging.

Full description

TIME-A is a longitudinal research initiative. Anyone who has ever taken an Index test registered through Elysium Health is eligible to participate. Participation involves answering questions that will be administered via a survey format. Research participants' survey responses will be combined with their epigenetic Index data with the primary aim of identifying the contributions of 1) environmental and lifestyle factors, 2) general health, and 3) medical history, on biological age. Exploratory aims include the development of epigenetic signatures that are predictive of health status, and exploring the relationship between epigenetically-derived health phenotypes and biological age. These findings will lay the foundation for personalized health recommendations using Index (including, but not limited to: workout routines, diets, supplement regimens, medications, lifestyle changes).

Enrollment: 25,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• All adults aged 18 and above
• Have registered at least one Index kit via the Elysium Health website
• Able and willing to provide digital consent to the Research Consent Form, and the TIME-A Research Subject Consent Form

Exclusion criteria

• Consent to participate not given

Trial design

25,000 participants in 1 patient group

TIME-A

Description:

Group will complete periodic surveys